tsdf (Q1354465)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
Two-/Three-Stage Designs for Phase 1&2 Clinical Trials
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | tsdf |
Two-/Three-Stage Designs for Phase 1&2 Clinical Trials |
Statements
26 April 2026
0 references
Calculates Zhong's optimal two-/three-stage Phase II designs for single-arm trials, generates target-toxicity decision tables for two-/three-stage Phase I dose-finding, and supports dose-finding simulations using custom decision tables. The Phase II design is based on Zhong (2012) <doi:10.1016/j.cct.2012.07.006>.
0 references
Jianan Hui
0 references
Bob Zhong
0 references
